Summit Trail Advisors, LLC Prothena Corp Public LTD CO Transaction History

Summit Trail Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$42.11 - $73.26 $126,330 - $219,780	-3,000 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$48.2 - $78.89 $144,600 - $236,670	3,000 New	3,000 $214,000
Q3 2018 Nov 14, 2018	SELL	$12.7 - $15.79 $7,683 - $9,552	-605 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$10.99 - $44.21 $97,360 - $391,656	-8,859 Reduced 93.61%	605 $9,000
Q1 2018 May 21, 2018	BUY	$27.95 - $45.04 $243,724 - $392,748	8,720 Added 1172.04%	9,464 $9,000
Q4 2017 Feb 14, 2018	BUY	$35.44 - $63.76 $26,367 - $47,437	744	744 $31,000

184

42.7M

151K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $657M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.